SCHEMBL21559196

SCHEMBL21559196

CC1(C)c2cc(-c3ccc4c(c3)-c3ccccc3C43c4ccccc4C(C)(C)c4ccccc43)ccc2-c2ccc(N(c3ccccc3)c3ccc(-c4ccccc4)cc3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 18/20 0.39
▸ MAPT P10636 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ PTBP1 P26599 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GALK1 P51570 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ SMAD3 P84022 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ATM Q13315 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21923874 0.99 PDK2 (0.40) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL24646826 0.98 PDK2 (0.38) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL23349316 0.98 PDK2 (0.39) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL23449669 0.97 PDK2 (0.41) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL21559086 0.97 PDK2 (0.37) PDK2MAPTL3MBTL1KDM4EALDH1A1
SCHEMBL24646686 0.96 PDK2 (0.40) PDK2MAPTL3MBTL1KDM4EALDH1A1
SCHEMBL21559017 0.96 PDK2 (0.36) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL21559353 0.96 PDK2 (0.37) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL16810679 0.96 PDK2 (0.37) PDK2MAPTL3MBTL1MEN1APAF1
SCHEMBL23222876 0.95 PDK2 (0.39) PDK2MAPTL3MBTL1MEN1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3567026-B1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG CHEMICAL LTD (KR) 2021-12-29 — — EP disclosed
US-20210143327-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN SOLUS CO., LTD. (KR) 2021-05-13 — — US disclosed
US-20200131112-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-04-30 — — US disclosed
EP-3567026-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG Chem, Ltd. (KR) 2019-11-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131112-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME AOX1, CYP1B1, CRY1 PDK2 2204/4885MAPT 2292/4885L3MBTL1 1336/4885
US-20210143327-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OR10J3, ICOSLG, L1CAM PDK2 1288/4885MAPT 1134/4885L3MBTL1 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback